Alcohol and Alcoholism Advance Access published online on December 29, 2005
Alcohol and Alcoholism, doi:10.1093/alcalc/agh250
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Molecular Psychiatry Laboratory, Windeyer Institute of Medical Science, Department of Mental Health Sciences, Royal Free and University College London, Medical School, 46 Cleveland Street, London W1T 4JF, UK; Kent Institute of Medicine and Health Science, University of Kent at Canterbury, UK
* To whom correspondence should be addressed. Aim: To review the process of identifying alcohol-dependent patients at risk of developing Wernicke's encephalopathy (WE) in the community, and prophylactic treatment options. Methods: Non-systematic literature review of the diagnosis of thiamine deficiency and of its treatment in the community. The role of supplementation of beer and bread with thiamine was evaluated. Results: The diagnosis of thiamine deficiency is not always made, and treatment apparently may sometimes be inadequate. Conclusions: Alcohol-dependent patients in the community who are at risk of developing WE should be given thiamine 250 mg, intramuscularly, daily for 3-5 days as part of a community detoxification programme. Further work is essential to determine the optimum dose of thiamine required to prevent permanent brain damage (Korsakoff's Psychosis). Neurotoxicity, due to the metabolism of excessive alcohol in patients with chronic and severe alcohol dependence, must be considered as an important factor in determining the long-term outcome of treatment.
Received December 21, 2004
Revised November 1, 2005
Accepted November 2, 2005
Article
THE TREATMENT OF PATIENTS AT RISK OF DEVELOPING WERNICKE'S ENCEPHALOPATHY IN THE COMMUNITY
ALLAN D. THOMSON 1
and
E. JANE MARSHALL 2 *
2 National Addiction Centre, Box 048, Institute of Psychiatry, Kings College London, De Crespigny Park, London SE5 8AF, UK
E. JANE MARSHALL, E-mail: jane.marshall{at}iop.kcl.ac.uk
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Ward, N. Murch, G. Agarwal, and D. Bell A multi-centre survey of inpatient pharmacological management strategies for alcohol withdrawal QJM, November 1, 2009; 102(11): 773 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A McKeon, M A Frye, and N. Delanty The alcohol withdrawal syndrome J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 854 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J R Parker, E J. Marshall, and D. M Ball Diagnosis and management of alcohol use disorders BMJ, March 1, 2008; 336(7642): 496 - 501. [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Thomson, C. C. H. Cook, I. Guerrini, D. Sheedy, C. Harper, and E. J. Marshall Wernicke's encephalopathy: 'plus ca change, plus c'est la meme chose' Alcohol Alcohol., March 1, 2008; 43(2): 180 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Thomson, C. C. H. Cook, I. Guerrini, D. Sheedy, C. Harper, and E. J. Marshall Review * Wernicke's encephalopathy revisited * Translation of the case history section of the original manuscript by Carl Wernicke 'Lehrbuch der Gehirnkrankheiten fur Aerzte and Studirende' (1881) with a commentary Alcohol Alcohol., March 1, 2008; 43(2): 174 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Habermeyer, M. Weiland, R. Mager, G. A. Wiesbeck, and F. M. Wurst Letter to the Editor * A clinical lesson: Glioblastoma multiforme masquerading as depression in a chronic alcoholic Alcohol Alcohol., January 1, 2008; 43(1): 31 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. YALDIZLI, F. M. WURST, S. EULER, B. WILLI, and G. WIESBECK MULTIPLE CEREBRAL METASTASES MIMICKING WERNICKE'S ENCEPHALOPATHY IN A CHRONIC ALCOHOLIC Alcohol Alcohol., November 1, 2006; 41(6): 678 - 680. [Abstract] [Full Text] [PDF]
|
|